Glucose Monitoring for A1GDM

Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Objective: The primary outcome is glucose value of the neonate at birth. Secondary

Objectives: Determine rates of insulin requirements within different monitoring techniques. Determine if there is a difference in neonatal intensive care unit (NICU) admission within different monitoring techniques. Determine neonatal blood glucose concentrations at 24 hours of life, number of glucose treatments, and neonatal hyperbilirubinemia. Secondary characteristics to be viewed for each diagnosis; BMI, race, age, and parity.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 51
Healthy Volunteers: f
View:

• All female patients of reproductive age (menarche-menopause: 18-51 years) who have the diagnosis diet controlled GDM

• Patient with singleton gestation presenting in labor or for induction

• Patients who had good glucose control and were A1GDM. Good Control;

‣ \- Patient with overall outpatient glucose average of less than 100

⁃ \- No evidence of fetopathy, large for gestational age or polyhydramnios.

⁃ \- Hgb A1c \<5.7

Locations
United States
New York
Mount Sinai West
New York
Time Frame
Start Date: 2024-12-05
Completion Date: 2025-05-30
Participants
Target number of participants: 100
Treatments
Infrequent
Patients will undergo one fingerstick on admission for their labor process.
Frequent
Patients will undergo fingersticks every 4 hours in latent labor and 2 hour in active labor during their labor process.
Sponsors
Leads: Icahn School of Medicine at Mount Sinai

This content was sourced from clinicaltrials.gov